IL-32
IL-32 (interleukin 32) is a secreted cytokine that may contribute to innate and adaptive immune responses. Also known as NK4, TAIF, TAIFb and TAIFd, it induces cytokines such as TNF-alpha and IL-8. Browse Assay Genie's current range of IL-32 research reagents below, or read on for the biology behind the target.
IL-32 is a cytokine that may play a role in both innate and adaptive immune responses. It induces the production of other cytokines, including TNF-alpha (TNF) and IL-8, and it activates the typical cytokine signalling pathways of NF-kappa-B and p38 MAPK. The NCBI Gene summary notes that the protein induces TNF-alpha production from macrophage cells, which places IL-32 upstream of several inflammatory mediators.
The IL32 gene encodes a member of the cytokine family and is classed by HGNC in the interleukins gene group. The IL-32 protein is secreted. According to the NCBI Gene summary, it contains a tyrosine sulfation site, three potential N-myristoylation sites, multiple putative phosphorylation sites and an RGD cell-attachment sequence. Alternative transcriptional splice variants encoding different isoforms have been characterised, so researchers working with the IL-32 protein should consider which isoform is relevant to their question.
Expression of IL-32 is increased after T-cells are activated by mitogens, and after NK cells are activated by IL-2. This link to lymphocyte activation explains the historical aliases NK4 and TAIF, and it makes IL-32 a useful readout in studies of cytokine networks, T-cell and NK cell activation, and the signalling events that follow.
IL-32 may contribute to both innate and adaptive immune responses, making it a candidate for studies of how cytokine networks coordinate immunity.
IL-32 induces cytokines such as TNF-alpha and IL-8, so it is used to examine how one cytokine drives production of others.
IL-32 activates the NF-kappa-B and p38 MAPK pathways, providing a route to study cytokine-driven intracellular signalling.
IL-32 expression rises after T-cell activation by mitogens or NK cell activation by IL-2, linking it to lymphocyte activation research.
IL-32 is a secreted cytokine that may play a role in innate and adaptive immune responses. It induces cytokines such as TNF-alpha and IL-8, and it activates the NF-kappa-B and p38 MAPK signalling pathways. It also induces TNF-alpha production from macrophage cells.
IL-32 is also known as NK4, TAIF, TAIFb and TAIFd, and its HGNC name is interleukin 32. The NCBI Gene summary reports that alternative transcriptional splice variants encode different isoforms, so it is worth confirming which isoform your experiment targets.
According to the NCBI Gene summary, IL-32 expression is increased after T-cells are activated by mitogens or NK cells are activated by IL-2. The gene is a member of the cytokine family and sits within the HGNC interleukins gene group.
Other interleukins and inflammatory cytokines that act in related immune and signalling pathways.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P24001; product specifications from Assay Genie datasheets.